Kreitman, R. J., Dearden, C., Zinzani, P. L., Delgado, J., Robak, T., le Coutre, P. D., . . . Giles, F. (2021). Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): Long-term follow-up from the pivotal trial. J Hematol Oncol.
Trích dẫn kiểu ChicagoKreitman, Robert J., et al. "Moxetumomab Pasudotox in Heavily Pre-treated Patients With Relapsed/refractory Hairy Cell Leukemia (HCL): Long-term Follow-up From the Pivotal Trial." J Hematol Oncol 2021.
Trích dẫn MLAKreitman, Robert J., et al. "Moxetumomab Pasudotox in Heavily Pre-treated Patients With Relapsed/refractory Hairy Cell Leukemia (HCL): Long-term Follow-up From the Pivotal Trial." J Hematol Oncol 2021.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.